HYPERCHOLESTEROLAEMIA
Clinical trials for HYPERCHOLESTEROLAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLAEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria pill could help control cholesterol
Disease control Recruiting nowThis study tests whether a daily probiotic called AKM Lab-01 can safely lower cholesterol levels in people with high cholesterol. About 60 adults aged 40-60 will take either the probiotic or a placebo for a period, and researchers will compare changes in their blood cholesterol a…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: NA • Sponsor: Moon (Guangzhou) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
One shot to tackle two heart risks? new combo drug enters human trials
Disease control Recruiting nowThis Phase 2 trial tests a new drug called HDY015, which combines two medicines (QCZ484 and inclisiran) into a single injection. The goal is to see if it can safely lower both blood pressure and cholesterol in people who have both conditions. About 120 adults aged 18-75 with hype…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New cholesterol drug showdown: could obicetrapib beat bempedoic acid?
Disease control Recruiting nowThis study tests a new drug called obicetrapib against another drug, bempedoic acid, to see which lowers 'bad' cholesterol more effectively. It involves 426 adults with high cholesterol who are already on maximum cholesterol medications and are at high risk for heart problems. Th…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE3 • Sponsor: A. Menarini International Licensing S.A. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
CRISPR therapy takes aim at stubborn high cholesterol in first human trial
Disease control Recruiting nowThis early-stage trial tests a new CRISPR-based treatment called CTX310 for people with severe cholesterol and triglyceride problems that don't improve with standard therapies. The treatment uses a tiny fat bubble to deliver gene-editing tools that turn off a gene linked to high …
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Italian registry checks if patients stay on cholesterol drug
Disease control Recruiting nowThis registry is tracking 1,500 Italian patients who are prescribed alirocumab 300 mg injections for high cholesterol. Researchers want to see how consistently patients take the medication and how well it lowers their cholesterol in real-life settings. The study also monitors sid…
Matched conditions: HYPERCHOLESTEROLAEMIA
Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New shot may slash cholesterol after heart attacks
Disease control Recruiting nowThis study tests whether adding inclisiran (a twice-yearly injection) to standard care lowers LDL cholesterol more than standard care alone in 520 patients who recently had a heart attack, stroke, or urgent heart procedure. Participants are randomly assigned to receive inclisiran…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC